Surgery Partners, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Surgery Partners, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, is 1.8 times its market value (net debt). Lower than 96% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 95% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $36 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 91% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
3.4×Over the last 3 years its own operating cash covered its investment spending (capex) 3.4 times.
Higher than 80% of Healthcare companies in United States.
Cash Locked Ratio
$13For every $100 of sales, $13 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $14 tied up three years earlier.
Less money tied up than 72% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
−$3Sales grew 30% in 3 years, but profit fell: $3 less profit per $100 of extra sales.
Lower than 70% of Healthcare companies in United States.
Asset Productivity Ratio
+30% / +22%In 3 years sales changed by +30% while total assets changed by +22%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
2.8×Debt due within a year is covered 2.8 times by its yearly operating cash.
Higher than 76% of Healthcare companies in United States.
Cash Cushion Ratio
1.8× debtDebt, after subtracting cash, is 1.8 times its market value (net debt).
Lower than 96% of Healthcare companies in United States.
Tangible Assets Ratio
36%Of every $100 the company owns, $36 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 91% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 95% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Surgery Partners, Inc. made a loss over the last year. Surgery Partners, Inc. owes $0.57 for every $1 it owns. Surgery Partners, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossSurgery Partners, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.25The share price is 1.25 times Surgery Partners, Inc.'s book value per share, lower than 74% of Healthcare companies in United States.
Market cap
$2.1 BThe total market value of all of Surgery Partners, Inc.'s shares at today's price (share price × number of shares), larger than 75% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$1.7 BWhat Surgery Partners, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$12.76Net worth divided by the number of shares. The share price of $15.90 is 1.2 times this, which is the P/B above.
Return on equity (ROE)
2.3%Surgery Partners, Inc. earned 2.3% on its shareholders' money over the last year, higher than 77% of Healthcare companies in United States.
Owes vs Owns
0.57×Surgery Partners, Inc. owes $0.57 for every $1 it owns (moderate), higher than 61% of Healthcare companies in United States.
Dividend yield
NoneSurgery Partners, Inc. does not currently pay a dividend.
Revenue growth
+6%Revenue rose 6% in the year to Dec 2025, and grew 9% a year on average over 3 years.
Profit growth
LossSurgery Partners, Inc. made a loss in each of the last two years.
Profit margin
-2.4%Surgery Partners, Inc. lost $2 for every $100 of revenue.
Interest cover
1.7×Surgery Partners, Inc.'s operating profit covered its interest costs 1.7 times in the year to Dec 2025.
Cash vs debt
Net debtSurgery Partners, Inc. had $3.8 B more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Surgery Partners, Inc.: $2.1 B ÷ $1.7 B (30 Jun 2026) = 1.2.
What is Surgery Partners, Inc.'s return on equity?
Surgery Partners, Inc. earned 2.3% on its shareholders' money over the last year, higher than 77% of Healthcare companies in United States.
How much does Surgery Partners, Inc. owe compared with what it owns?
Surgery Partners, Inc. owes $0.57 for every $1 it owns (moderate), higher than 61% of Healthcare companies in United States.
Does Surgery Partners, Inc. pay a dividend?
No. Surgery Partners, Inc. does not currently pay a dividend.
Is Surgery Partners, Inc.'s revenue growing?
Revenue rose 6% in the year to Dec 2025, and grew 9% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.